arrow
S

Sherrie Bhoori

fondazione ircc istituto nazionale tumori
H指数:36
被引数:9,198

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune-checkpoint inhibitors for advanced hepatocellular carcinoma in Child–Turcotte–Pugh-B cirrhosis: a liver-centric approach to outcomes beyond tumor progression

免疫检查点抑制剂用于Child–Turcotte–Pugh-B级肝硬化患者的晚期肝细胞癌:一种以肝脏为中心的、超越肿瘤进展的治疗效果评估方法

2026-05-220
PRE
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab

丙型肝炎清除可改善接受阿替利珠单抗联合贝伐珠单抗治疗患者的肿瘤学和临床结局

2025-09-220
PREAI
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management

伦伐替尼在晚期甲状腺癌、唾液腺癌、子宫内膜癌和肝细胞癌中的应用:一项关于治疗持续时间与毒性管理的真实世界研究

2025-09-120
OA
Liver transplantation for hepatitis D virus/hepatitis B virus coinfection in Italy: An intention-to-treat analysis of long-term outcomes

意大利丁型肝炎病毒/乙型肝炎病毒合并感染患者的肝移植:一项长期结局的意向性治疗分析

2025-03-070
OAAI
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study

MASLD患者的等待名单死亡率和5年移植生存获益: 一项意大利肝移植登记研究

2024-09-012
OAAI
TKIs treatment for HCC before Liver transplantation: an ELITA/ELTR collaborative study
2024-02-010
OAAI
The IMPROVEMENT project: first report of the global liver transplant activity
2024-02-010
PRE
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients
2023-07-032
OAAI
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

HIV相关肝细胞癌抗癌免疫反应的综合表型分析

2023-07-011
OAAI
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center

实体瘤患者的mRNA anti-SARS-CoV-2疫苗接种的功效和体液免疫反应的动态: 来自意大利三级癌症中心的机构注册结果

2022-07-270
OAAI
Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative study
2022-05-013
OAAI